# Xcellerate Biotech, Inc. — Form D

Xcellerate Biotech, Inc. of Rockville, MD, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-27. The offering totals $719K, of which $719K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-08-27
- Form: D
- Accession: 0001795036-20-000001
- Industry: Biotechnology
- Exemptions: 06b, 4a5
- Total offering: $719K
- Amount sold: $719K
- Minimum investment: $719K
- Investors: 1
- Date of first sale: 2020-08-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-374274

## Issuer

- Name: Xcellerate Biotech, Inc.
- CIK: 0001795036
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 13212 Valley Drive, Rockville, MD, 20850
- Phone: 240-620-2394

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Peter Dolan | Director | Bedford, MA |
| Peter Dolan | Executive Officer | Bedford, MA |
| Peter Dolan | Promoter | Bedford, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-12-05](https://search.stillhousedata.com/formd/0001795036-19-000001) | D | $345K | $345K |

## More

- [CIK 1795036 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1795036&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001795036-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.